Britain’s first national adviser for LGBT+ health has said the roll-out of a highly effective HIV prevention pill could save hundreds of thousands of pounds for the country’s publicly funded health authority.
Health authorities in England said on Friday that they support a plan to double to 26 000 the number of participants in an HIV prevention pill trial, ahead of a potential national roll-out.
Patient associations on Thursday lauded an EU decision to allow the sale of generic versions of Truvada, an anti-retroviral medicine used by those diagnosed HIV-positive, the virus causing AIDS.
Students at the University of Limpopo are among those from eleven universities across the country that have launched the roll-out plan for an HIV prevention pill, Truvada.
SABC © 2019